Outcomes for Patients Aged 12–18 Months With Metastatic <i>MYCN</i> Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project

Mixed biology toddlers have lower EFS and OS compared to those whose tumors have favorable biologic features. Inclusion in high-risk NBL trials should be considered for this rare subgroup.

Authors

Institutions

Publication Details

Journal
Pediatric Blood & Cancer
Published
2025-08-29
DOI
https://doi.org/10.1002/pbc.31968
Primary Topic
Neuroblastoma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project

Wendy B. London, Julie R. Park, Keri A. Streby, Miki Ohira et al.
Pediatric Blood & Cancer
Neuroblastoma Research and Treatments
article

Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project

Wendy B. London, Julie R. Park, Keri A. Streby, Miki Ohira, Meredith S. Irwin, James R. Anderson, Sara Michele Federico, Pei‐Chi Kao, Mark A. Applebaum, Carolina Rosswog, Thomas F. Cash, Navin Pinto, Mallory Taylor
article en

Abstract

Mixed biology toddlers have lower EFS and OS compared to those whose tumors have favorable biologic features. Inclusion in high-risk NBL trials should be considered for this rare subgroup.

Pediatric Blood & CancerVol. 72(11)
St. Jude Children's Research Hospital (US), Nationwide Children's Hospital (US), Harvard University (US), Emory University (US), University of Toronto (CA), University of Washington (US), Hospital for Sick Children (CA), University of Chicago (US), Seattle Children's Hospital (US), Aflac (United States) (US), Saitama Cancer Center (JP), SickKids Foundation (CA), Children's Healthcare of Atlanta (US), University Hospital Cologne (DE), Dana-Farber/Boston Children's Cancer and Blood Disorders Center (US), University of Nebraska Medical Center (US), University of Colorado Denver (US)
Openalex Percentile: Top 67%
Neuroblastoma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.